Results 201 to 210 of about 32,807 (224)

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Truong NH, Benaboud S, Bouazza N, Deneuville E, Mornand A, Reix P, Ribault M, Burgel PR, Froelicher-Bournaud L, Rouillon S, Sanoufi MR, Lui G, Urien S, Tréluyer JM, Sermet-Gaudelus I, Foissac F, Modul‐CF study group.   +16 more
europepmc   +1 more source

Success in the Application of Laser Velocimetry in Turbomachinery Studies

, 1986
Schodl, R., Dunker, R., Krain, H., Binder, A.   +3 more
core  

Canonical ETI-Dependent and -Independent Pathways Mediate Autoimmunity Caused by Loss of CBP60b Clade Function. [PDF]

Mol Plant Pathol
Li LS, Yang YY, Ma L, Wang SL, Li S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis

Journal of Cystic Fibrosis, 2022
Kevin Scully, Rebecca Cagnina, Manuela Cernadas   +2 more
exaly  

The combination elexacaftor/tezacaftor/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner

Journal of Cystic Fibrosis, 2023
Pietro Franceschi, Mar Garcia-Aloy, Nara Liessi   +2 more
exaly  

Proteomics of PTI and Two ETI Immune Reactions in Potato Leaves

International Journal of Molecular Sciences, 2019
Muhammad Awais Zahid, Fredrik Levander, Svante Resjo   +2 more
exaly  

Astrotheology and the ETI Myth

Theology and Science, 2009
Ted Peters
exaly  

The ETI Myth: Idolatrous Fantasy or Plausible Inference?

Theology and Science, 2010
Albert A Harrison
exaly  

Both Light-Induced SA Accumulation and ETI Mediators Contribute to the Cell Death Regulated by BAK1 and BKK1

Frontiers in Plant Science, 2017
Jia Li, Kai He, Yujun Wu
exaly